Literature DB >> 23508801

Partial summary measures of the predictiveness curve.

Michael C Sachs1, Xiao-Hua Zhou.   

Abstract

In the evaluation of a biomarker for risk prediction, one can assess the performance of the biomarker in the population of interest by displaying the predictiveness curve. In conjunction with an assessment of the classification accuracy of a biomarker, the predictiveness curve is an important tool for assessing the usefulness of a risk prediction model. Inference for a single biomarker or for multiple biomarkers can be performed using summary measures of the predictiveness curve. We propose two partial summary measures, the partial total gain and the partial proportion of explained variation, that summarize the predictiveness curve over a restricted range of risk. The methods we describe can be used to compare two biomarkers when there are existing thresholds for risk stratification. We describe inferential tools for one and two samples that are shown to have adequate power in a simulation study. The methods are illustrated by assessing the accuracy of a risk score for predicting the onset of Alzheimer's disease.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Biomarker; Classification; Prediction; Summary statistic

Mesh:

Year:  2013        PMID: 23508801      PMCID: PMC3806283          DOI: 10.1002/bimj.201200146

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  14 in total

1.  Assessing risk prediction models in case-control studies using semiparametric and nonparametric methods.

Authors:  Ying Huang; Margaret Sullivan Pepe
Journal:  Stat Med       Date:  2010-06-15       Impact factor: 2.373

2.  Spline-based models for predictiveness curves and surfaces.

Authors:  Debashis Ghosh; Michael Sabel
Journal:  Stat Interface       Date:  2010-01-01       Impact factor: 0.582

3.  Properties of R(2) statistics for logistic regression.

Authors:  Bo Hu; Mari Palta; Jun Shao
Journal:  Stat Med       Date:  2006-04-30       Impact factor: 2.373

4.  Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929).

Authors:  M S Pepe; Z Feng; J W Gu
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

5.  Integrating the predictiveness of a marker with its performance as a classifier.

Authors:  Margaret S Pepe; Ziding Feng; Ying Huang; Gary Longton; Ross Prentice; Ian M Thompson; Yingye Zheng
Journal:  Am J Epidemiol       Date:  2007-11-02       Impact factor: 4.897

6.  Explained variation for logistic regression.

Authors:  M Mittlböck; M Schemper
Journal:  Stat Med       Date:  1996-10-15       Impact factor: 2.373

7.  Semiparametric methods for evaluating risk prediction markers in case-control studies.

Authors:  Ying Huang; Margaret Sullivan Pepe
Journal:  Biometrika       Date:  2009-10-12       Impact factor: 2.445

8.  The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Authors:  John C Morris; Sandra Weintraub; Helena C Chui; Jeffrey Cummings; Charles Decarli; Steven Ferris; Norman L Foster; Douglas Galasko; Neill Graff-Radford; Elaine R Peskind; Duane Beekly; Erin M Ramos; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

9.  A parametric ROC model-based approach for evaluating the predictiveness of continuous markers in case-control studies.

Authors:  Y Huang; M S Pepe
Journal:  Biometrics       Date:  2009-12       Impact factor: 2.571

Review 10.  Effective pharmacologic management of Alzheimer's disease.

Authors:  Martin R Farlow; Jeffrey L Cummings
Journal:  Am J Med       Date:  2007-05       Impact factor: 4.965

View more
  1 in total

1.  Predictiveness curves in virtual screening.

Authors:  Charly Empereur-Mot; Hélène Guillemain; Aurélien Latouche; Jean-François Zagury; Vivian Viallon; Matthieu Montes
Journal:  J Cheminform       Date:  2015-11-04       Impact factor: 5.514

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.